NASDAQ:SNBP Sun BioPharma (SNBP) Stock Price, News & Analysis → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free SNBP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$3.45▼$4.5052-Week Range N/AVolume49,422 shsAverage Volume26,926 shsMarket Capitalization$3.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesTrendsStock AnalysisCompetitorsHeadlinesTrends Get Sun BioPharma alerts: Email Address Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. About Sun BioPharmaSun BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics treatment for unmet medical needs. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. Sun BioPharma, Inc. was founded in 2011 and is based in Waconia, Minnesota.Read More Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does not care.I have uncovered a bombshell that changes everything… and threatens everything. SNBP Stock News HeadlinesMay 29, 2024 | msn.comBuy Sun Pharmaceutical Industries; target of Rs 1710: Prabhudas LilladherMay 28, 2024 | reuters.comAs four-year doping ban ends, China's Sun eyes return to poolMay 28, 2024 | msn.comBuy Sun Pharmaceutical Industries; target of Rs 1,827: KR ChokseyMay 23, 2024 | msn.comSun Pharma shares tumble 5% but brokerages raise target up to Rs 1,785. Should you buy, sell or hold?May 23, 2024 | msn.comSun Pharmaceutical Industries Q4 Results Live : profit rise by 33.77% YOYMay 23, 2024 | msn.comSun Pharma Shares In The Red After Giving Low Guidance For Coming YearMay 23, 2024 | msn.comSun Pharma Share Price Target 2024: Rs 5 DIVIDEND in Q4 results; BUY, SELL or HOLD?May 22, 2024 | msn.comSun Pharma Q4FY24 PAT grows 34% to Rs 2,655 cr; Rs 5 per share dividend declaredMay 22, 2024 | msn.comSun Pharma Q4 net profit up by 34%May 22, 2024 | msn.comSun Pharma Q4 FY 2024: 500% DIVIDEND announced, stock up 1.5 per cent as company announces quarterly earningsMay 22, 2024 | reuters.comIndia's Sun Pharma beats Q4 profit view on strong US, domestic salesMay 22, 2024 | reuters.comIndia's Sun Pharma beats Q4 profit estimatesMay 21, 2024 | msn.comSun Pharma Q4 Results 2024 Date and Time: Dividend news, quarterly earnings preview, expectationsMay 21, 2024 | markets.businessinsider.comHere's what to expect from Sun Pharmaceutical's earningsMay 21, 2024 | msn.comSun Pharma Q4 Results Preview: Net profit likely to rise 18% with steady marginMay 21, 2024 | msn.comSun Pharma Q4 preview: Strong speciality drug sales, Revlimid contribution, domestic growth to aid earningsApril 29, 2024 | msn.comSun Pharma gets Rs 1.11 crore tax demandApril 16, 2024 | msn.comAnother regulatory blow for Sun Pharma after Dadra unit tagged 'OAI' by US FDA, stock downApril 12, 2024 | msn.comSun Pharma Shares Nosedive 3% After Inspection Notice From FDAApril 12, 2024 | msn.comSun Pharma Slumps Over 2% Early In The Day As Markets Start In RedApril 12, 2024 | msn.comSun Pharma shares trade 3.4% lower following US FDA regulatory actionApril 11, 2024 | msn.comSun Pharma abandons Parkinson's drug trialApril 11, 2024 | msn.comSun Pharma halts trial of its Parkinson’s disease drug as it fails to show “treatment benefits”April 10, 2024 | seekingalpha.comABUS Arbutus Biopharma CorporationMarch 27, 2024 | bbc.co.ukTips for staying safe in the sunSee More Headlines Receive SNBP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sun BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/12/2020Today6/02/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:SNBP CUSIPN/A CIKN/A Webwww.sunbiopharma.com Phone952-479-1196FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares9,649,000Free FloatN/AMarket Cap$3.96 million OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesDr. Michael T. Cullen Jr. (Age 74)Co-Founder & Exec. Chairman Comp: $282.35kMs. Susan Horvath (Age 61)VP of Fin., CFO, Sec. & Treasurer Comp: $220.31kDr. Jennifer K. Simpson (Age 52)CEO, Pres & Director Dr. Thomas X. NeenanCo-Founder & Chief Scientific OfficerMs. Tammy GroeneVP of OperationsDr. Suzanne Gagnon (Age 63)Chief Medical Officer & Director More ExecutivesKey CompetitorsTraws PharmaNASDAQ:TRAWNeuroSense TherapeuticsNASDAQ:NRSNAkari TherapeuticsNASDAQ:AKTXKiora PharmaceuticalsNASDAQ:KPRXEdesa BiotechNASDAQ:EDSAView All Competitors SNBP Stock Analysis - Frequently Asked Questions How were Sun BioPharma's earnings last quarter? Sun BioPharma, Inc. (NASDAQ:SNBP) issued its earnings results on Thursday, November, 12th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.09. What other stocks do shareholders of Sun BioPharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sun BioPharma investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO). This page (NASDAQ:SNBP) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sun BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.